FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313574782> ?p ?o ?g. }

• W4313574782 endingPage "88" @default.
• W4313574782 startingPage "88" @default.
• W4313574782 abstract "We aimed to assess the factors associated with mortality in patients treated with tocilizumab for a SARS-CoV-2 pneumonia due to the delta or omicron variants of concern (VOC) and detect an effect of tocilizumab on mortality. We conducted a prospective cohort study in a tertiary hospital from 1 August 2021 to 31 March 2022 including patients with severe COVID-19, treated with tocilizumab. Factors associated with mortality were assessed in a Cox model; then, the 60-day mortality rates of COVID-19 patients treated with standard of care (SoC) +/− tocilizumab were compared after 1:1 propensity score matching. The mortality rate was 22% (N = 26/118) and was similar between delta and omicron cases (p = 0.6). The factors independently associated with mortality were age (HR 1.06; 95% CI (1.02–1.11), p = 0.002), Charlson index (HR 1.33; 95% CI (1.11–1.6), p = 0.002), WHO-CPS (HR 2.56; 95% CI (1.07–6.22) p = 0.03), and tocilizumab infusion within the first 48 h following hospital admission (HR 0.37, 95% CI (0.14–0.97), p = 0.04). No significant differences in mortality between the tocilizumab plus SoC and SoC alone groups (p = 0.5) were highlighted. However, the patients treated with tocilizumab within the 48 h following hospital admission had better survival (p = 0.04). In conclusion, our results suggested a protective effect on mortality of the early administration of tocilizumab in patients with severe COVID-19 regardless of the VOC involved." @default.
• W4313574782 created "2023-01-06" @default.
• W4313574782 creator A5002432212 @default.
• W4313574782 creator A5008175951 @default.
• W4313574782 creator A5010343899 @default.
• W4313574782 creator A5010472421 @default.
• W4313574782 creator A5025821107 @default.
• W4313574782 creator A5037466528 @default.
• W4313574782 creator A5045615372 @default.
• W4313574782 creator A5049289579 @default.
• W4313574782 creator A5063850780 @default.
• W4313574782 creator A5072379220 @default.
• W4313574782 creator A5075869737 @default.
• W4313574782 creator A5076260413 @default.
• W4313574782 creator A5076778444 @default.
• W4313574782 creator A5080946396 @default.
• W4313574782 creator A5081843575 @default.
• W4313574782 date "2023-01-04" @default.
• W4313574782 modified "2023-10-11" @default.
• W4313574782 title "Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France" @default.
• W4313574782 cites W2000445173 @default.
• W4313574782 cites W3016538467 @default.
• W4313574782 cites W3016661132 @default.
• W4313574782 cites W3018269482 @default.
• W4313574782 cites W3030243311 @default.
• W4313574782 cites W3034858522 @default.
• W4313574782 cites W3043975336 @default.
• W4313574782 cites W3047144258 @default.
• W4313574782 cites W3093604087 @default.
• W4313574782 cites W3093693178 @default.
• W4313574782 cites W3110844195 @default.
• W4313574782 cites W3112984291 @default.
• W4313574782 cites W3129869280 @default.
• W4313574782 cites W3130126061 @default.
• W4313574782 cites W3174691049 @default.
• W4313574782 cites W3176700190 @default.
• W4313574782 cites W3181530483 @default.
• W4313574782 cites W3193623972 @default.
• W4313574782 cites W3203643732 @default.
• W4313574782 cites W3216190636 @default.
• W4313574782 cites W4206449744 @default.
• W4313574782 cites W4207033867 @default.
• W4313574782 cites W4210642183 @default.
• W4313574782 cites W4210651074 @default.
• W4313574782 cites W4210800842 @default.
• W4313574782 cites W4214709934 @default.
• W4313574782 cites W4220965701 @default.
• W4313574782 cites W4224950216 @default.
• W4313574782 cites W4226181138 @default.
• W4313574782 cites W4226192094 @default.
• W4313574782 cites W4281258049 @default.
• W4313574782 cites W4283803192 @default.
• W4313574782 cites W4292466650 @default.
• W4313574782 cites W4293367208 @default.
• W4313574782 cites W4293515374 @default.
• W4313574782 cites W4296836712 @default.
• W4313574782 cites W4309269461 @default.
• W4313574782 cites W4311665916 @default.
• W4313574782 doi "https://doi.org/10.3390/antibiotics12010088" @default.
• W4313574782 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36671288" @default.
• W4313574782 hasPublicationYear "2023" @default.
• W4313574782 type Work @default.
• W4313574782 citedByCount "0" @default.
• W4313574782 crossrefType "journal-article" @default.
• W4313574782 hasAuthorship W4313574782A5002432212 @default.
• W4313574782 hasAuthorship W4313574782A5008175951 @default.
• W4313574782 hasAuthorship W4313574782A5010343899 @default.
• W4313574782 hasAuthorship W4313574782A5010472421 @default.
• W4313574782 hasAuthorship W4313574782A5025821107 @default.
• W4313574782 hasAuthorship W4313574782A5037466528 @default.
• W4313574782 hasAuthorship W4313574782A5045615372 @default.
• W4313574782 hasAuthorship W4313574782A5049289579 @default.
• W4313574782 hasAuthorship W4313574782A5063850780 @default.
• W4313574782 hasAuthorship W4313574782A5072379220 @default.
• W4313574782 hasAuthorship W4313574782A5075869737 @default.
• W4313574782 hasAuthorship W4313574782A5076260413 @default.
• W4313574782 hasAuthorship W4313574782A5076778444 @default.
• W4313574782 hasAuthorship W4313574782A5080946396 @default.
• W4313574782 hasAuthorship W4313574782A5081843575 @default.
• W4313574782 hasBestOaLocation W43135747821 @default.
• W4313574782 hasConcept C11988809 @default.
• W4313574782 hasConcept C126322002 @default.
• W4313574782 hasConcept C17923572 @default.
• W4313574782 hasConcept C179755657 @default.
• W4313574782 hasConcept C188816634 @default.
• W4313574782 hasConcept C2777178219 @default.
• W4313574782 hasConcept C2777575956 @default.
• W4313574782 hasConcept C2777914695 @default.
• W4313574782 hasConcept C2778690821 @default.
• W4313574782 hasConcept C2779134260 @default.
• W4313574782 hasConcept C3008058167 @default.
• W4313574782 hasConcept C524204448 @default.
• W4313574782 hasConcept C71924100 @default.
• W4313574782 hasConceptScore W4313574782C11988809 @default.
• W4313574782 hasConceptScore W4313574782C126322002 @default.
• W4313574782 hasConceptScore W4313574782C17923572 @default.
• W4313574782 hasConceptScore W4313574782C179755657 @default.
• W4313574782 hasConceptScore W4313574782C188816634 @default.

• next